Stock comparison
Medtronic
Thermo Fisher Scientific
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MDT
Medtronic
Market cap
$97.77B
Sector
Healthcare
TMO
Thermo Fisher Scientific
Market cap
$162.9B
Sector
Healthcare
Overall winner
Medtronic MDT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MDT | TMO | Winner |
|---|---|---|---|
| Warren Buffett | 50C | 44D | MDT |
| Benjamin Graham | 57C | 64C | TMO |
| Philip Fisher |
Side-by-side metrics
| Metric | MDT | TMO |
|---|---|---|
| Market cap | $97.77B | $162.9B |
| P/E (TTM) | 21.2x | 23.8x |
| EV/EBIT | 20.9x | 25.0x |
| ROIC (TTM) | 6.43% | 7.33% |
| Gross margin | 61.95% | 39.41% |
| Net margin | 13.0% | 15.18% |
| Revenue CAGR 5y | 2.73% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MDT leads on
- EPS CAGR 5y7.88%vs -2.43%+131%
- Dividend yield3.73%vs 0.4%+89%
- Gross margin61.95%vs 39.41%+36%
- Debt / Equity0.6xvs 0.8x
More like TMO
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.